Lista de obras - Yohan Suryo Rahmanto - Dominio Público Uruguay

Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.

artículo científico publicado en 2008

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti‐tumour efficacy ⬇️

artículo científico publicado el 1 de enero de 2012

Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes

artículo científico publicado en 2011

Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes

artículo científico publicado en 2018

Differential regulation of the Menkes and Wilson disease copper transporters by hormones: an integrated model of metal transport in the placenta

artículo científico publicado en 2007

Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant

artículo científico publicado en 2009

Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotype

artículo científico publicado en 2009

Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood.

artículo científico publicado en 2009

Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo

artículo científico

Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia

artículo científico publicado en 2012

Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.

artículo científico publicado en 2016

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming

artículo científico publicado en 2020

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors

scientific article published on 27 May 2015

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.

artículo científico publicado en 2018

Inhibition of the MYC-regulated glutaminase metabolic axis is an effective synthetic lethal approach for treating chemoresistant cancers

artículo científico publicado en 2020

Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53.

artículo científico publicado en 2009

Iron uptake and metabolism in the new millennium.

artículo científico publicado en 2006

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

artículo científico publicado en 2019

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review

scientific article published on 10 November 2018

Melanotransferrin: search for a function.

artículo científico

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma

artículo científico publicado en 2017

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.

artículo científico publicado en 2013

Nitric Oxide Storage and Transport in Cells Are Mediated by Glutathione S-Transferase P1-1 and Multidrug Resistance Protein 1 via Dinitrosyl Iron Complexes ⬇️

artículo científico publicado el 14 de noviembre de 2011

Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins

artículo científico publicado en 2012

Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates

artículo científico publicado en 2005

Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines

artículo científico publicado en 2012

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer

scientific article published on 03 September 2019

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

artículo científico publicado en 2019

The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.

artículo científico publicado en 2006

The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia.

artículo científico publicado en 2009

The medicinal chemistry of novel iron chelators for the treatment of cancer.

artículo científico publicado en 2011

The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.

artículo científico publicado en 2007

The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity.

artículo científico publicado en 2011

The translational regulator eIF3a: the tricky eIF3 subunit!

artículo científico publicado en 2010

Therapeutic Inducers of Apoptosis in Ovarian Cancer

scientific article published on 13 November 2019

Lista de obras de Yohan Suryo Rahmanto

Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti‐tumour efficacy ⬇️

Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes

Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes

Differential regulation of the Menkes and Wilson disease copper transporters by hormones: an integrated model of metal transport in the placenta

Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant

Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotype

Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood.

Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo

Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia

Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.

Inhibition of the MYC-regulated glutaminase metabolic axis is an effective synthetic lethal approach for treating chemoresistant cancers

Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53.

Iron uptake and metabolism in the new millennium.

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review

Melanotransferrin: search for a function.

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.

Nitric Oxide Storage and Transport in Cells Are Mediated by Glutathione S-Transferase P1-1 and Multidrug Resistance Protein 1 via Dinitrosyl Iron Complexes ⬇️

Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins

Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates

Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.

The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia.

The medicinal chemistry of novel iron chelators for the treatment of cancer.

The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.

The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity.

The translational regulator eIF3a: the tricky eIF3 subunit!

Therapeutic Inducers of Apoptosis in Ovarian Cancer